EMPLOYMENT AGREEMENTEmployment Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 9th day of October, 2013, by and between Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), and Donna Nichols, an individual (the “Executive”).
RECRO PHARMA, INC. AWARD AGREEMENT FOR [employee’s name]Award Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations
This award is subject in all respects to the applicable provisions of the Plan, a complete copy of which has been furnished to you and receipt of which you acknowledge by acceptance of the award. Such provisions are incorporated herein by reference and made a part hereof (including all defined terms).
NON-INJECTABLE DEXMEDETOMIDINE LICENSE AGREEMENT between RECRO PHARMA, INC. and ORION CORPORATION DATED AS OF AUGUST 22, 2008License Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
THIS INVESTOR RIGHTS AGREEMENT (“Agreement”) is entered into as of September 4, 2008, by and among Recro Pharma, Inc., a Pennsylvania corporation, f/k/a Rēcro Pharma 1, Inc. (the “Company”), and the investors listed on Schedule A attached hereto (each, an “Investor” and collectively, the “Investors”).
OFFICE SERVICES AGREEMENTOffice Services Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
This Office Services Agreement is made on January 1, 2012, between Malvern Consulting Group, having offices at 490 Lapp Road, Malvern, PA 19355 (“MCG”) and Recro Pharma, Inc. (“Licensee”).
FIRST AMENDMENT TO NON-INJECTABLE DEXMEDETOMIDINE LICENSE AGREEMENT OF AUGUST 22, 2008Dexmedetomidine License Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations
This amendment agreement (hereinafter referred to as the “Amendment”) is made and executed as of this 17th day of January, 2009 by and between:
DEXMEDETOMIDINE API SUPPLY AGREEMENTApi Supply Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations
This API Supply Agreement (the “Agreement”) is entered into this 22nd day of August, 2008 (the “Effective Date”), by and among Recro Pharma, Inc., a company incorporated under the laws of the Commonwealth of Pennsylvania (“Customer” or “Recro”), and Orion Corporation, a company incorporated under the laws of Finland (“Supplier” or “Orion”). Customer and Supplier may each be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
Amendment #1 to Office Services AgreementOffice Services Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations
This Amendment #1 (“Amendment”) to the Office Services Agreement dated January 1, 2012 (the “Agreement”) by and between Malvern Consulting Group, Inc. (“MCG”) and Recro Pharma, Inc. (“Licensee”) is entered into and effective as of October 3, 2013.
MASTER CONSULTING SERVICES AGREEMENTMaster Consulting Services Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
This Master Consulting Services Agreement (this “Agreement”) is made and entered into as of this 10th day of October, 2013, by and between Malvern Consulting Group, Inc., a Pennsylvania corporation (“Consultant”) and Recro Pharma, Inc., a Pennsylvania corporation (“Client”).
